Choosing the most appropriate one depends, among other things, on the situation of each patient: what gametes they have (eggs or sperm), their fertility and whether they have a partner with whom they share their family project.
Increase your pregnancy chances even more with the most appropriate add-on techniques for your treatment. Your doctor will advise you which ones are best for you, depending on your diagnosis.
Embryos that do not have impurities between their cells have a better prognosis in their development. These impurities are pieces of cell membranes, debris from their cytoplasmic division processes and hinder the compacting between cells, that is, they prevent them from joining together to form all the structures of the embryo. They slow down its development and can impede its evolution.
We call the process of removing these residual fragments to enhance the embryo’s developmental potential “Embryo Fragment Removal”.
Thanks to the Polaraide, with the polarisation of the light in the microscope, it is possible to visualise much better the maturation state of the oocyte to know the exact moment in which we must perform the microinjection of the sperm for its fertilisation (ICSI). In addition, this technology allows us to clearly see the most important structures of the egg, the nucleus and the meiotic spindle where its genetic information is located. With this technique we will avoid damaging them during ICSI and increase the fertilisation rate.
In In Vitro Fertilisation treatments, the Polaraide is especially indicated when the patient develops few oocytes. These are called “high value oocytes”.
The IMSI technology makes it possible to observe spermatozoa with a magnification of up to 16,000 times, while the conventional microscope used in In Vitro Fertilisation treatments reaches 400 times magnification.
In this way it is possible to select very precisely the sperm with the best morphology in order to subsequently fertilise the egg by means of sperm microinjection (ICSI).
It involves a meticulous process in which the sperm are chosen one by one, as many as we have mature oocytes to fertilise. IMSI is the abbreviation of the name of this technique: Intra-cytoplasmic Morphologically-selected Sperm Injection (IMSI).
Intracytoplasmic Sperm Injection (ICSI) is a technique used in In Vitro Fertilisation treatments that involves injecting a sperm with the help of a micropipette directly into the oocyte to achieve fertilisation. This technique is indicated in the first IVF cycle, in cases of sterility of unknown origin or when there are few eggs. It ensures fertilisation and multiplies the chances of achieving a good result in your treatment.
The Preimplantation Genetic Test (PGT) allows us to analyse the chromosomal content of the embryos obtained by In Vitro Fertilisation and to transfer only those that do not present anomalies and have a better chance of implantation. We use the most advanced technique: Next Sequency Generation.
To carry out this analysis, after IVF, on the fifth day of embryo development, one of the embryo’s cells is removed (biopsy). The embryo is vitrified until the PGT results are obtained, fourteen days later. In this way, we can choose the best one for the embryo transfer, increasing the pregnancy rates and decreasing the risk of miscarriage. It is especially indicated in women over 37 years old, in the case of low sperm quality and repeated IVF failures.
The Preimplantation Genetic Test can be performed when the embryo is in its third day of development. In this case we call it PGT Express because it is not necessary to freeze the embryo to wait for the results: in 48 hours we will have its analysis and we will be able to transfer it “fresh”.
The chromosomal analysis is carried out, in all cases, by means of the most advanced technique: Next Sequency Generation.
The incubation of the embryos until the fifth day of development or long culture allows the selection of the best embryos for In Vitro Fertilisation treatment.
By observing the development of the embryos from day 3 to day 5 or 6 we can discard those that do not divide correctly and choose those that have a real chance of implanting. Blastocyst culture increases the probability of success by embryo transfer and reduces the transfer of non-viable embryos.
To select the best embryos, biologists take into account their evolution while they are developing: from the day of fertilisation to the moment of transfer. The Embryoscope is a state-of-the-art incubator that makes it possible to monitor embryo division live without having to remove the embryos from the incubator. Thanks to time-lapse technology, biologists can monitor them in real time, avoiding the temperature changes and oxidative stress that would be caused by having to look at them under a microscope outside the incubator. This new technology maintains the optimal physiological conditions for the development of your embryos and provides us with a film of the beginning of life. You will also be able to see it on your mobile phone through the Embryomobile.
Thanks to the Embryomobile, you will be able to see how your embryos are developing in the IVF laboratory from the day of fertilisation to the day of the transfer. All patients who use the Embryoscope can observe online and free of charge the images of their embryos in real time from home.
Our studies prove that the Embryomobile reduces anxiety and improves embryo implantation. It is also an exercise in transparency.
The “Genetic Compatibility Test” is a blood test that detects these mutations (currently the 420 genes that cause the most common diseases).
It analyses, by means of massive sequencing and other techniques, 420 genes related to recessive or X-linked pathologies, in order to evaluate the reproductive risk. Comparing the results of both members of a couple we will know if it coincides that both are carriers of the same alteration.
If there is genetic incompatibility in relation to a serious disease, in an In Vitro Fertilisation treatment, the embryos can be genetically analysed and the affected ones can be avoided to be transferred.
Babypod is a small speaker for intravaginal use that allows you to share music and communicate with your baby during pregnancy. Thanks to Babypod, your baby will have its first musical experience and will be able to hear your voice clearly from the 16th week of pregnancy onwards. By placing this speaker inside the vagina, the barrier of the abdominal wall is eliminated and the baby can hear the sounds almost as loudly and clearly as they are emitted.
Babypod is the only scientifically endorsed product of its kind. It has received awards from Harvard University and the Massachusetts Institute of Technology (MIT) and is FDA approved. Visit the store here.